Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrei Shustov, MD
Seattle Cancer Care Alliance, Seattle, WA, USA
Principal Investigator - Astrid Pavlovsky, MD
Centro de Hematologia, FUNDALEU, Buenos Aires, Argentina
Principal Investigator - Attilio Guarini, MD
U.O. Ematologia, IRCCS Istituto Tumori "Giovanni Paolo II"
Principal Investigator - Carlos Chiattone, MD
Departamento de Clinica Médica, FCM da Santa Casa de Sao Paulo, Sao Paulo, Brazil
Principal Investigator - Christopher Fox, MD
Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK
Principal Investigator - Dolores Caballero, MD
Instituto Biosanitaria de Salamanca, Salamanca, Spain
Principal Investigator - Francesco Zaya, MD
Azienda Sanitaria Universitaria Integrata S.M. Misericordia, Udine, Italy
Principal Investigator - Francine Foss, MD
Yale University School of Medicine, New Haven, CT, USA
Principal Investigator - Julie Vose, MD
Section of Hematology/Oncology, Nebraska Medical Center, USA
Principal Investigator - Kim Won Seog, MD
Hematology-Oncology Samsung Medical Center, Seoul, South Korea
Principal Investigator - Massimo Federico, MD
University of Modena and Reggio Emilia, Centro Oncologico Modenese, Modena, Italy
Study Director - Miles Prince, MD
Peter MacCallum Cancer Center, Melbourne, Australia
Principal Investigator - Pierluigi Porcu, MD
Hematopoietic Stem Cell Transplantation, Sidney Kimmel Cancer Center, USA
Principal Investigator - Ranjana Advani, MD
Stanford University Medical Center, Stanford, CA, USA
Principal Investigator - Stefano Luminari, MD
S.C. Ematologia, Arcispedale S. Maria Nuova-IRCCS, Reggio Emilia, Italy
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Irccs Istituto Tumori "giovanni Paolo Ii"
Bari, Italy
Recruiting - Palermo_la Maddalena
Palermo, Italy
Not, yet, recruiting - Terni-Santa Maria
Terni, Italy
Not, yet, recruiting
- Cluj Napoca_ion Chiricuta Oncology Institute
Cluj-Napoca, Romania
Recruiting
- National Cancer Institute
Kiev, Ukraine
Recruiting
- Stanford University
Stanford, California, United States
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Oct 2018
- Primary completion
- 30 Jul 2025
- Completion
- 30 Jul 2025
- Last update posted
- 6 May 2025
- Registered enrollment
- 1,000
- Registry id
- NCT03964480
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.